Arcutis Biotherapeutics (ARQT) is up 15% Friday as the Street applauded new prescription data for the company's psoriasis cream Zoryve.
https://seekingalpha.com/news/3984664-arcutis-up-15-growth-prescriptions-zoryve-psoriasis-cream
Arcutis Biotherapeutics (ARQT) is up 15% Friday as the Street applauded new prescription data for the company's psoriasis cream Zoryve.
https://seekingalpha.com/news/3984664-arcutis-up-15-growth-prescriptions-zoryve-psoriasis-cream
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.